Russia's Pharmasyntez seeks permission to produce COVID-19 drug without patent

US FDA Approves Kala Pharmaceuticals' Eysuvis for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease

IAVI, Merck, and Serum Institute of India Team to Develop Monoclonal Antibodies for COVID-19

IAVI, the Serum Institute of India Pvt Ltd and Merck KGaA to develop potent neutralizing antibodies for COVID-19

Chugai Pharmaceutical announces first 9 months 2020 financial results

Amgen announces Q4 2020 dividend

Avantor Inc announces Mandatory Convertible Preferred Stock quarterly cash dividend

Eli Lilly announces Q4 dividend

Johnson & Johnson receives European Commission approval for COVID-19 vaccine supply to EU member states

Johnson & Johnson to distribute 200m doses of COVID-19 vaccine candidate across the EU

CVS Health Corporation announces quarterly dividend

ABEC's CSR technology to support production of 1bn doses of Novavax COVID-19 vaccine by Serum Institute

India's Serum Institute receives additional USD150m funding to make an additional 100 million COVID-19 vaccine doses

Pfizer declares fourth-quarter 2020 dividend

EU signs its second COVID-19 vaccine deal with Sanofi and GSK